insights_auto
Why is EYPT down 85.51%?
Dive Deeperchevron_right
EYPT:NASDAQ
EyePoint Inc
$0.43
arrow_downward
-85.51%(-2.56) 1D
Oct 19, 1:31:14 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EYPT...
Open
$0.55
High
$0.60
Low
$0.40
Mkt. cap
37.35M
Avg. vol.
3.20M
Volume
145.46M
52-wk high
$19.01
52-wk low
$0.40
EPS
-$3.74
Beta
1.67
Shares outstanding
86.21M
No. of employees
214
Open
$0.55
High
$0.60
Low
$0.40
Mkt. cap
37.35M
Avg. vol.
3.20M
Volume
145.46M
52-wk high
$19.01
52-wk low
$0.40
EPS
-$3.74
Beta
1.67
Shares outstanding
86.21M
No. of employees
214
News stories
From web sources and news partners
Benzinga
·
22 minutes ago
EyePoint Slashing Workforce, Halting Clinical Trials to Pivot Focus
Benzinga
·
33 minutes ago
12 Health Care Stocks Moving In Monday's Intraday Session
News Corp
·
42 minutes ago
EyePoint Drug Trial Flop Crashes Stock. Can a Strategy Shift Save It?
BioSpace
·
47 minutes ago
EyePoint will halve workforce, end pivotal wet AMD trials early following second fail
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees214
Founded2000
HeadquartersWatertown, Massachusetts, United States
SectorPharmaceutical industry
Websiteeyepoint.bio